JORDAN ANDREW R 4
4 · Aceragen, Inc. · Filed Feb 2, 2023
Insider Transaction Report
Form 4
Aceragen, Inc.ACGN
JORDAN ANDREW R
Chief Strategy Officer
Transactions
- Award
Stock Options (Right to Buy)
2023-01-20+25,400→ 25,400 totalExercise: $5.21Exp: 2033-01-20→ Common Stock (25,400 underlying)
Footnotes (1)
- [F1]The stock option award was granted under the Issuer's 2022 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on January 20, 2023. Twenty-five percent (25%) of the stock option vests and becomes exercisable on January 20, 2024 (first anniversary of the date of grant) and the balance vests in thirty-six equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.